Lee, Hannah M.
Ahn, Joseph
Kim, W. Ray
Lim, Joseph K.
Nguyen, Mindie
Pan, Calvin Q.
Kim, Donghee
Mannalithara, Ajitha
Te, Helen
Trinh, Huy
Chu, Danny
Tran, Tram
Woog, Jocelyn
Lok, Anna S.
Funding for this research was provided by:
Bristol-Myers Squibb
Article History
Received: 12 June 2018
Accepted: 7 September 2018
First Online: 20 September 2018
Compliance with ethical standards
:
: Hannah Lee and Joseph Ahn have no disclosures. Anna S. Lok has research grant support from Bristol-Myers Squibb, Gilead Sciences and NIH Grant U01 DK082863. Mindie Nguyen has research support from BMS, Gilead, Janssen, National Cancer Institute, Pfizer. She is on the Advisory board/consultant for Janssen, Novartis, Gilead, Alnylam, Dynavax, Spring Bank, Intercept. Calvin Pan is a speaker, consultant for Bristol-Myers Squibb. Helen Te has research grant support from Abbvie, Conatus, Bristol-Myers Squibb. She is on the Advisory board for Bristol-Myers Squibb. Danny Chu is on the Advisory board and speaker’s bureau for Gilead Sciences. Tram Tran has Research grant support from Bristol-Myers Squibb and Gilead Sciences. She is on the Advisory board for Bristol-Myers Squibb and Gilead Sciences. There is no other disclosures for all other authors.
: Hannah Lee confirms that this work is original and has not been published elsewhere nor is it currently under consideration for publication elsewhere. Hannah Lee is acting as the submission’s guarantor and takes responsibility for the integrity of the work as a whole, from inception to published article. All authors approved the final version of the article.